Xin (Sheen) Xu
Lawyers
Filters
Zeekr Group going-private transaction
We advised Zeekr Group on the transaction
VNET $137.7 million private placement
We advised VNET on the transaction
Adagene $70 million registered direct offering
We advised Adagene on the offering
Pony AI HK$6.71 billion dual primary listing on the Hong Kong Stock Exchange
We advised Pony AI on its dual primary listing on HKEX
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Adagene $25 million strategic equity investment from Sanofi
We advised Adagene on the transaction
VNET Group $430 million convertible senior notes offering
We advised VNET Group on the transaction
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
Adagene $100 million at-the-market offering
We advised Adagene on the offering